Details for Patent: 12,324,838
Which drugs does patent 12,324,838 protect, and when does it expire?
Patent 12,324,838 protects NEFFY and is included in one NDA.
This patent has eighty-six patent family members in thirty-four countries.
Summary for Patent: 12,324,838
| Title: | Intranasal epinephrine formulations and methods for the treatment of disease |
| Abstract: | Drug products adapted for nasal delivery comprising formulations with epinephrine and devices comprising such formulations are provided. Methods of treating anaphylaxis with epinephrine products are also provided. |
| Inventor(s): | Richard Lowenthal, Edward T. Maggio, Robert G. Bell, Pratik Shah |
| Assignee: | Aegis Therapeutics LLC |
| Application Number: | US18/327,621 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 12,324,838 |
|
Patent Claim Types: see list of patent claims | Formulation; Compound; Device; |
Drugs Protected by US Patent 12,324,838
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ars Pharms Operation | NEFFY | epinephrine | SPRAY;NASAL | 214697-002 | Mar 5, 2025 | RX | Yes | Yes | 12,324,838 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Ars Pharms Operation | NEFFY | epinephrine | SPRAY;NASAL | 214697-001 | Aug 9, 2024 | RX | Yes | Yes | 12,324,838 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,324,838
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3678649 | ⤷ Start Trial | 301317 | Netherlands | ⤷ Start Trial |
| European Patent Office | 3678649 | ⤷ Start Trial | CA 2025 00007 | Denmark | ⤷ Start Trial |
| European Patent Office | 3678649 | ⤷ Start Trial | PA2025507 | Lithuania | ⤷ Start Trial |
| European Patent Office | 3678649 | ⤷ Start Trial | C20250011 | Finland | ⤷ Start Trial |
| European Patent Office | 3678649 | ⤷ Start Trial | 122025000010 | Germany | ⤷ Start Trial |
| European Patent Office | 3678649 | ⤷ Start Trial | LUC00378 | Luxembourg | ⤷ Start Trial |
| European Patent Office | 3678649 | ⤷ Start Trial | 2025C/508 | Belgium | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
